Cargando…

A dried blood spot protocol for high throughput analysis of SARS-CoV-2 serology based on the Roche Elecsys anti-N assay

BACKGROUND: Since 2020 SARS-CoV-2 spreads pandemically, infecting more than 119 million people, causing >2·6 million fatalities. Symptoms of SARS-CoV-2 infection vary greatly, ranging from asymptomatic to fatal. Different populations react differently to the disease, making it very hard to track...

Descripción completa

Detalles Bibliográficos
Autores principales: Beyerl, Jessica, Rubio-Acero, Raquel, Castelletti, Noemi, Paunovic, Ivana, Kroidl, Inge, Khan, Zohaib N., Bakuli, Abhishek, Tautz, Andreas, Oft, Judith, Hoelscher, Michael, Wieser, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320407/
https://www.ncbi.nlm.nih.gov/pubmed/34333234
http://dx.doi.org/10.1016/j.ebiom.2021.103502
_version_ 1783730642186403840
author Beyerl, Jessica
Rubio-Acero, Raquel
Castelletti, Noemi
Paunovic, Ivana
Kroidl, Inge
Khan, Zohaib N.
Bakuli, Abhishek
Tautz, Andreas
Oft, Judith
Hoelscher, Michael
Wieser, Andreas
author_facet Beyerl, Jessica
Rubio-Acero, Raquel
Castelletti, Noemi
Paunovic, Ivana
Kroidl, Inge
Khan, Zohaib N.
Bakuli, Abhishek
Tautz, Andreas
Oft, Judith
Hoelscher, Michael
Wieser, Andreas
author_sort Beyerl, Jessica
collection PubMed
description BACKGROUND: Since 2020 SARS-CoV-2 spreads pandemically, infecting more than 119 million people, causing >2·6 million fatalities. Symptoms of SARS-CoV-2 infection vary greatly, ranging from asymptomatic to fatal. Different populations react differently to the disease, making it very hard to track the spread of the infection in a population. Measuring specific anti-SARS-CoV-2 antibodies is an important tool to assess the spread of the infection or successful vaccinations. To achieve sufficient sample numbers, alternatives to venous blood sampling are needed not requiring medical personnel or cold-chains. Dried-blood-spots (DBS) on filter-cards have been used for different studies, but not routinely for serology. METHODS: We developed a semi-automated protocol using self-sampled DBS for SARS-CoV-2 serology. It was validated in a cohort of matched DBS and venous-blood samples (n = 1710). Feasibility is demonstrated with two large serosurveys with 10247 company employees and a population cohort of 4465 participants. FINDINGS: Sensitivity and specificity reached 99·20% and 98·65%, respectively. Providing written instructions and video tutorials, 99·87% (4465/4471) of the unsupervised home sampling DBS cards could be analysed. INTERPRETATION: DBS-sampling is a valid and highly reliable tool for large scale serosurveys. We demonstrate feasibility and accuracy with a large validation cohort including unsupervised home sampling. This protocol might be of big importance for surveillance in resource-limited settings, providing low-cost highly accurate serology data. FUNDING: Provided by Bavarian State Ministry of Science and the Arts, LMU University-Hospital; Helmholtz-Centre-Munich, German Ministry for Education and Research (project01KI20271); University of Bonn; University of Bielefeld; the Medical Biodefense Research Program of Bundeswehr-Medical-Service; Euroimmun, RocheDiagnostics provided discounted kits and machines
format Online
Article
Text
id pubmed-8320407
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-83204072021-07-29 A dried blood spot protocol for high throughput analysis of SARS-CoV-2 serology based on the Roche Elecsys anti-N assay Beyerl, Jessica Rubio-Acero, Raquel Castelletti, Noemi Paunovic, Ivana Kroidl, Inge Khan, Zohaib N. Bakuli, Abhishek Tautz, Andreas Oft, Judith Hoelscher, Michael Wieser, Andreas EBioMedicine Research Paper BACKGROUND: Since 2020 SARS-CoV-2 spreads pandemically, infecting more than 119 million people, causing >2·6 million fatalities. Symptoms of SARS-CoV-2 infection vary greatly, ranging from asymptomatic to fatal. Different populations react differently to the disease, making it very hard to track the spread of the infection in a population. Measuring specific anti-SARS-CoV-2 antibodies is an important tool to assess the spread of the infection or successful vaccinations. To achieve sufficient sample numbers, alternatives to venous blood sampling are needed not requiring medical personnel or cold-chains. Dried-blood-spots (DBS) on filter-cards have been used for different studies, but not routinely for serology. METHODS: We developed a semi-automated protocol using self-sampled DBS for SARS-CoV-2 serology. It was validated in a cohort of matched DBS and venous-blood samples (n = 1710). Feasibility is demonstrated with two large serosurveys with 10247 company employees and a population cohort of 4465 participants. FINDINGS: Sensitivity and specificity reached 99·20% and 98·65%, respectively. Providing written instructions and video tutorials, 99·87% (4465/4471) of the unsupervised home sampling DBS cards could be analysed. INTERPRETATION: DBS-sampling is a valid and highly reliable tool for large scale serosurveys. We demonstrate feasibility and accuracy with a large validation cohort including unsupervised home sampling. This protocol might be of big importance for surveillance in resource-limited settings, providing low-cost highly accurate serology data. FUNDING: Provided by Bavarian State Ministry of Science and the Arts, LMU University-Hospital; Helmholtz-Centre-Munich, German Ministry for Education and Research (project01KI20271); University of Bonn; University of Bielefeld; the Medical Biodefense Research Program of Bundeswehr-Medical-Service; Euroimmun, RocheDiagnostics provided discounted kits and machines Elsevier 2021-07-29 /pmc/articles/PMC8320407/ /pubmed/34333234 http://dx.doi.org/10.1016/j.ebiom.2021.103502 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Paper
Beyerl, Jessica
Rubio-Acero, Raquel
Castelletti, Noemi
Paunovic, Ivana
Kroidl, Inge
Khan, Zohaib N.
Bakuli, Abhishek
Tautz, Andreas
Oft, Judith
Hoelscher, Michael
Wieser, Andreas
A dried blood spot protocol for high throughput analysis of SARS-CoV-2 serology based on the Roche Elecsys anti-N assay
title A dried blood spot protocol for high throughput analysis of SARS-CoV-2 serology based on the Roche Elecsys anti-N assay
title_full A dried blood spot protocol for high throughput analysis of SARS-CoV-2 serology based on the Roche Elecsys anti-N assay
title_fullStr A dried blood spot protocol for high throughput analysis of SARS-CoV-2 serology based on the Roche Elecsys anti-N assay
title_full_unstemmed A dried blood spot protocol for high throughput analysis of SARS-CoV-2 serology based on the Roche Elecsys anti-N assay
title_short A dried blood spot protocol for high throughput analysis of SARS-CoV-2 serology based on the Roche Elecsys anti-N assay
title_sort dried blood spot protocol for high throughput analysis of sars-cov-2 serology based on the roche elecsys anti-n assay
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320407/
https://www.ncbi.nlm.nih.gov/pubmed/34333234
http://dx.doi.org/10.1016/j.ebiom.2021.103502
work_keys_str_mv AT beyerljessica adriedbloodspotprotocolforhighthroughputanalysisofsarscov2serologybasedontherocheelecsysantinassay
AT rubioaceroraquel adriedbloodspotprotocolforhighthroughputanalysisofsarscov2serologybasedontherocheelecsysantinassay
AT castellettinoemi adriedbloodspotprotocolforhighthroughputanalysisofsarscov2serologybasedontherocheelecsysantinassay
AT paunovicivana adriedbloodspotprotocolforhighthroughputanalysisofsarscov2serologybasedontherocheelecsysantinassay
AT kroidlinge adriedbloodspotprotocolforhighthroughputanalysisofsarscov2serologybasedontherocheelecsysantinassay
AT khanzohaibn adriedbloodspotprotocolforhighthroughputanalysisofsarscov2serologybasedontherocheelecsysantinassay
AT bakuliabhishek adriedbloodspotprotocolforhighthroughputanalysisofsarscov2serologybasedontherocheelecsysantinassay
AT tautzandreas adriedbloodspotprotocolforhighthroughputanalysisofsarscov2serologybasedontherocheelecsysantinassay
AT oftjudith adriedbloodspotprotocolforhighthroughputanalysisofsarscov2serologybasedontherocheelecsysantinassay
AT hoelschermichael adriedbloodspotprotocolforhighthroughputanalysisofsarscov2serologybasedontherocheelecsysantinassay
AT wieserandreas adriedbloodspotprotocolforhighthroughputanalysisofsarscov2serologybasedontherocheelecsysantinassay
AT adriedbloodspotprotocolforhighthroughputanalysisofsarscov2serologybasedontherocheelecsysantinassay
AT beyerljessica driedbloodspotprotocolforhighthroughputanalysisofsarscov2serologybasedontherocheelecsysantinassay
AT rubioaceroraquel driedbloodspotprotocolforhighthroughputanalysisofsarscov2serologybasedontherocheelecsysantinassay
AT castellettinoemi driedbloodspotprotocolforhighthroughputanalysisofsarscov2serologybasedontherocheelecsysantinassay
AT paunovicivana driedbloodspotprotocolforhighthroughputanalysisofsarscov2serologybasedontherocheelecsysantinassay
AT kroidlinge driedbloodspotprotocolforhighthroughputanalysisofsarscov2serologybasedontherocheelecsysantinassay
AT khanzohaibn driedbloodspotprotocolforhighthroughputanalysisofsarscov2serologybasedontherocheelecsysantinassay
AT bakuliabhishek driedbloodspotprotocolforhighthroughputanalysisofsarscov2serologybasedontherocheelecsysantinassay
AT tautzandreas driedbloodspotprotocolforhighthroughputanalysisofsarscov2serologybasedontherocheelecsysantinassay
AT oftjudith driedbloodspotprotocolforhighthroughputanalysisofsarscov2serologybasedontherocheelecsysantinassay
AT hoelschermichael driedbloodspotprotocolforhighthroughputanalysisofsarscov2serologybasedontherocheelecsysantinassay
AT wieserandreas driedbloodspotprotocolforhighthroughputanalysisofsarscov2serologybasedontherocheelecsysantinassay
AT driedbloodspotprotocolforhighthroughputanalysisofsarscov2serologybasedontherocheelecsysantinassay